173 related articles for article (PubMed ID: 17311393)
1. Total synthesis of azumamide A and azumamide E, evaluation as histone deacetylase inhibitors, and design of a more potent analogue.
Wen S; Carey KL; Nakao Y; Fusetani N; Packham G; Ganesan A
Org Lett; 2007 Mar; 9(6):1105-8. PubMed ID: 17311393
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into azumamide e histone deacetylases inhibitory activity.
Maulucci N; Chini MG; Micco SD; Izzo I; Cafaro E; Russo A; Gallinari P; Paolini C; Nardi MC; Casapullo A; Riccio R; Bifulco G; Riccardis FD
J Am Chem Soc; 2007 Mar; 129(10):3007-12. PubMed ID: 17311384
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis, NMR solution structure, and binding model of the potent histone deacetylase inhibitor FR235222.
Rodriquez M; Terracciano S; Cini E; Settembrini G; Bruno I; Bifulco G; Taddei M; Gomez-Paloma L
Angew Chem Int Ed Engl; 2006 Jan; 45(3):423-7. PubMed ID: 16311994
[No Abstract] [Full Text] [Related]
4. Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222.
Di Micco S; Terracciano S; Bruno I; Rodriquez M; Riccio R; Taddei M; Bifulco G
Bioorg Med Chem; 2008 Sep; 16(18):8635-42. PubMed ID: 18715788
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E.
Villadsen JS; Stephansen HM; Maolanon AR; Harris P; Olsen CA
J Med Chem; 2013 Aug; 56(16):6512-20. PubMed ID: 23865683
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand.
Nishino N; Yoshikawa D; Watanabe LA; Kato T; Jose B; Komatsu Y; Sumida Y; Yoshida M
Bioorg Med Chem Lett; 2004 May; 14(10):2427-31. PubMed ID: 15109626
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of cyclic tetrapeptide FR235222, a potent immunosuppressant that inhibits mammalian histone deacetylases.
Xie W; Zou B; Pei D; Ma D
Org Lett; 2005 Jun; 7(13):2775-7. PubMed ID: 15957944
[TBL] [Abstract][Full Text] [Related]
8. Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases.
Bhuiyan MP; Kato T; Okauchi T; Nishino N; Maeda S; Nishino TG; Yoshida M
Bioorg Med Chem; 2006 May; 14(10):3438-46. PubMed ID: 16439135
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of cyclopeptide analogues of the potent histone deacetylase inhibitor FR235222.
Gomez-Paloma L; Bruno I; Cini E; Khochbin S; Rodriquez M; Taddei M; Terracciano S; Sadoul K
ChemMedChem; 2007 Oct; 2(10):1511-9. PubMed ID: 17694590
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylases.
Grolla AA; Podestà V; Chini MG; Di Micco S; Vallario A; Genazzani AA; Canonico PL; Bifulco G; Tron GC; Sorba G; Pirali T
J Med Chem; 2009 May; 52(9):2776-85. PubMed ID: 19344175
[TBL] [Abstract][Full Text] [Related]
11. Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.
Jose B; Oniki Y; Kato T; Nishino N; Sumida Y; Yoshida M
Bioorg Med Chem Lett; 2004 Nov; 14(21):5343-6. PubMed ID: 15454224
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of a potent histone deacetylase inhibitor.
Liu T; Kapustin G; Etzkorn FA
J Med Chem; 2007 May; 50(9):2003-6. PubMed ID: 17419603
[TBL] [Abstract][Full Text] [Related]
13. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.
Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A
J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342
[TBL] [Abstract][Full Text] [Related]
14. Total synthesis of azumamide E and sugar amino acid-containing analogue.
Chandrasekhar S; Rao CL; Seenaiah M; Naresh P; Jagadeesh B; Manjeera D; Sarkar A; Bhadra MP
J Org Chem; 2009 Jan; 74(1):401-4. PubMed ID: 19053574
[TBL] [Abstract][Full Text] [Related]
15. 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.
Jones P; Bottomley MJ; Carfí A; Cecchetti O; Ferrigno F; Lo Surdo P; Ontoria JM; Rowley M; Scarpelli R; Schultz-Fademrecht C; Steinkühler C
Bioorg Med Chem Lett; 2008 Jun; 18(11):3456-61. PubMed ID: 18440229
[TBL] [Abstract][Full Text] [Related]
16. Optimization of a series of potent and selective ketone histone deacetylase inhibitors.
Pescatore G; Kinzel O; Attenni B; Cecchetti O; Fiore F; Fonsi M; Rowley M; Schultz-Fademrecht C; Serafini S; Steinkühler C; Jones P
Bioorg Med Chem Lett; 2008 Oct; 18(20):5528-32. PubMed ID: 18809328
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis of spiruchostatin A, a potent histone deacetylase inhibitor.
Yurek-George A; Habens F; Brimmell M; Packham G; Ganesan A
J Am Chem Soc; 2004 Feb; 126(4):1030-1. PubMed ID: 14746465
[TBL] [Abstract][Full Text] [Related]
18. Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework.
Shivashimpi GM; Amagai S; Kato T; Nishino N; Maeda S; Nishino TG; Yoshida M
Bioorg Med Chem; 2007 Dec; 15(24):7830-9. PubMed ID: 17881232
[TBL] [Abstract][Full Text] [Related]
19. Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides.
Nishino N; Shivashimpi GM; Soni PB; Bhuiyan MP; Kato T; Maeda S; Nishino TG; Yoshida M
Bioorg Med Chem; 2008 Jan; 16(1):437-45. PubMed ID: 17900911
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-amino-8-oxodecanoic acids (Aodas) present in natural hystone deacetylase inhibitors.
Rodriquez M; Bruno I; Cini E; Marchetti M; Taddei M; Gomez-Paloma L
J Org Chem; 2006 Jan; 71(1):103-7. PubMed ID: 16388624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
